College of the Holy Spirit

Golden Gate University

Ateneo de Manila University

Finance Consultant at Spruce Biosciences

San Mateo, California, United States

Spruce Biosciences is a late-stage biopharmaceutical company focused on developing and commercializing novel therapies for rare endocrine disorders with significant unmet need. The company is initially developing its wholly-owned product candidate, tildacerfont, as the potential first non-steroidal therapy to offer markedly improved disease control and reduce steroid burden for patients suffering from classic congenital adrenal hyperplasia (CAH). Duties: PCAOB Review, pre-IPO readiness, re-audit of FYE2017-FYE2020 (30-JUN-20) for the S-1 Filing (completed within 39 days), SOX 404 Narrative, R&D Accruals, Clinical Trials Accrual, various Financial Model CRO’s BvA flux analysis, worked directly with CMO, CRO, ClinDev, DevOps, CMC, Non-Clin Dev, Biostatistics, PK, Regulatory & Quality, PO R&D Accruals Master Sheet, Quarterly\Annual Variance CTA Summary, Clinical Consultants, financial statements

Spruce Biosciences

Finance Consultant

Consultant has over 18 years of finance & accounting experience-both private & publicly held companies & non-profit sectors. Project oriented contracts, either short term or long-term engagement & some through agency affiliation. Average length of stay is 6 months & last as long as 4-6 years.
-  Biotech/Pharma Industries: Clinical Trials accrual accounting; accountability for analysis for clinical trials/clinical dev & analysis plans metrics (Kindred Biosciences, Inc., OneWorld Health, PATH, GNE, Intermune) • SOX 404 compliance-Finance lead; ASC 830 FAS 52; Support key business initiatives • Developed matrix for Rev Rec: (ASC 606 Adoption Process ASC 605/SAB 104, SOP 97-2); Accounting for Cost of SW Development (SC 350-40/SOP 98-1) • ROI/ROE analytics; Lease Accounting; Identify Key Performance Indicators (KPI); Identify Key Operations Indicators (KOI) • Financial statement compilation, bench marking cost centers, CFlow projection, flux analysis, consolidation; revenue forecasting, deferred revenue, deferred compensation 409A, contract pricing; tax provision & 123R preparation footnotes & disclosure checklists • Cost Accounting (PPV), CAPEX; P&L Profitability in depth analysis; Proactively researches, documents conclusions on accounting issues with appropriate references to relevant GAAP pronouncements • Documents abnormalities or significant changes, takes corrective action where necessary and reports this information to management

- Examples of Client Engagement:
Commercial warehouses & RE holdings; Global Upside; Jagx, Kindred Biosciences, Inc., DWG, Iterable Inc., Curse; R+F, ERP/Tax Return/Internal Audit, Bridges SF LLC, eQuest, Jajah, Telefonica, DZH Phillips, Smith Lange Phillips, Hlaska, Genetech, Visa, Intermune, CCCYO, WageWorks, SF Ballet Assoc, SF Parks Trust, Brandeis Hillel Day School, Ocadian, GES, <a href="http://COLO.Com">COLO.Com</a>, J.L. Morgan Enterprise, Inc., L/GCSF, Theatrical Hairgoods Company, Zuckerman & McQuiller, Callaway & Wolf, Tucker Alan, Impact Media

MB Services

Executive Controller, Interim CFO, Finance Consultant

2019 Interim Controller for Iterable, Inc. a growth marketing platform with an integrated cross-channel solution -built for marketers, trusted by engineers and designed with intelligence. Duties: Month End Close Full Cycle with balance sheet reconciliation and review & financial statement; Payroll Review with labor & benefits allocation reconciliation; PR Tax Returns & SOD review; successfully implemented NS OneWorld with seamless integration of current <a href="http://Bill.com">Bill.com</a>, Expensify & WFN platform; created Corp Credit Card Policy, Travel Policy, Fixed Asset & Expenditures Policy, How To Approve or Deny Bills in <a href="http://Bill.com">Bill.com</a> with Approval Workflow Matrix SOP, updated Treasury & Cash Management Narrative, 2 versions of Investment Policy, reviewed SBC expense calculation, CAP Table & Equity Accounting (Carta); Corp Tax Return Review; ASC606 documentation; PBC Audit List preparation & review in conjunction with external auditor, Armanino

Iterable

Interim Controller

Interim Controller for JAGX
Jaguar Health, Inc. (NASDAQ: JAGX) is a commercial stage pharmaceuticals company focused on developing novel, sustainably derived gastrointestinal products on a global basis. Our wholly-owned subsidiary, Napo Pharmaceuticals, Inc., focuses on developing and commercializing proprietary human gastrointestinal pharmaceuticals for the global marketplace from plants used traditionally in rainforest areas. Our Mytesi® (crofelemer) product is approved by the U.S. FDA for the symptomatic relief of noninfectious diarrhea in adults with HIV/AIDS on antiretroviral therapy.

Global Upside

Assoc. Dir, Finance: 2015 – 2018 Acting Controller (Consultant): Aug 2014 to Apr 2015, Q3-2018
-  Timely filing: monthly/quarterly accounting close process for a publicly-traded accelerated filer – 3rd business day close
-  Preparation & Oversight of payroll function: prep/review/audit, labor allocation, PR Tax Returns, sales commission, EE Benefits
-  Primary Lead for Sarbanes-Oxley 404 compliance- sourced SOX Consultants; narratives, RCM & SOC 1 Mapping
-  Successful ERP Implementation of NetSuite OneWorld, Adaptive Planning, Expensify, ADP Workforce Now, AvidXchange, DNBi, Runzheimer, Oomnitza (Asset Management platform); BioSolve (COGs calc) generated savings (30-90% discount) in excess of $525k for 2017
-  Successfully filed IRS Form 8974 & resulted in total $500k R&D Credit for 2016 & 2017
-  Annual Audit & Tax Returns: Worker’s Comp, Personal Property Tax, Annual Meeting, CT Corp Annual Audit, Quarterly & Annual Audit PBC List, Flux Analysis, Financial Modeling & Dashboard Reporting
-  Automated R&D Accruals through customized workflow in NetSuite; Clinical Trials Accrual process improvement through CTMS
-  Pivotal role in readying the accounting team for the company's first product launch including accounting for inventory, COGS and revenue recognition in a manufacturing environment

Kindred Biosciences, Inc.

Assoc. Dir, Finance: 2015 – 2018 Acting Controller (Consultant): Aug 2014 to Apr 2015, Q3-2018

- Finance In Depth Assessment part of Organizational Strategic & Sustainability Plan; ERP Implementation System Conversion; ERP Business Intelligence Capabilities Pricing Analysis; UCOA Design & Re-Mapping; Departmental Account Structure; Design Cash Flow Statement & Cash Burn Rate Spreadsheet; Financial Statements; Audit Reconciliation spreadsheet formulation & staff training; 990 15 month Audit completion; End to End Accounting; Payroll; Dashboard reports; Performance Metrics; various ad hoc projects & reports**
- Assists Interim Controller on various t/con q&a inquiries e.g. system conversion- pro bono through Aug 2013

San Francisco Botanical Garden Society

Consulting CFO

- Monthly Financial Statement Executive Team & Quarterly BOD Financial Statements with full disclosure; Fund Accounting/Fund Balances ~$30MM reconciliation; Global UK/India Donor Reporting to BMGF,DFID, UBS, et al; FAS 52 revaluation & retranslation; Audit Preparation; Due Diligence; Facilitated Transition Planning & Execution working collaboratively with Path, iOWH & Bill & Melinda Gates Foundation BMGF; various ad hoc reports analytics, roll forward schedules and balance sheet accounts reconciliation

PATH (The Institute for OneWorld Health, An Affiliate of PATH)

Engaged to address GOLIVE Issues of GP ERP Implementation; streamlined SOP Integration (Data Flow & Support to Lindalu &
NW to GP Revenue Reconciliation); Complex account reconciliation; structured AR reconciliation & AR Roll forward Schedule, Customer Deposit Liability; COGS Analytics; POP Receipts - quantity difference and other issue handling; Monthly Reporting: Open Orders, Canceled Orders, Pending Sale, Manual Credits, Replacement Orders:SKU Sales with Cost at Item Level; GP Year-end close - run close process for all modules; General support for GP issues - all areas; Projects - lead or support on various projects involving GP included but not limited to Integration Manager, FRx Report Specs Development; Budget Uploads; Inventory Reconciliation for RNI; SSRS Report ad hoc specifications

Stella & Dot

- Successful completion of 2008 audit research, calculation, account reconciliation, FAS13 Analysis, Deferred Rent calculation, FA, AR Roll forward schedule, AR Reserve Analysis for 2007 & 2008, data validation/compilation of Dentrix ERP conversion to Open Dental, In Depth Analysis of Doubtful Accounts, P&L Flux analysis, Prepaid & Accrued Expenses Analysis, AP Aged Payables Reconciliation & Analysis, PR Analytics, Onsite Foundation review

OnSite Health

Audit Accountant Project Consultant

- Great Plains ERP Implementation: multi-national manufacturing firm with presence in APAC, EMEA & Americas; Multi-national consolidation setup, UCOA design, GL historical data upload
- Inter-Company transactions & reconciliation, FAS52 revaluation & reconciliation
- Master Data Fields for AP, AR, Inventory (BOM) & BR (bank rec), elimination accounts, CTA accounts; Data validation & reconciliation of financial data for accuracy & completeness
- Defined & developed US Frx reports: Balance Sheet with Ratios, Income Statement, Actual vs. Budget flux Analysis, FASB Cash Flow Statements, Cash Flow with Projection, Deferred Revenue/Revenue Recognition, ad hoc projects

Envivio

System Finance Consultant - Manufacturing

- Complex account reconciliation; Flux analysis, Accruals review, Sales Contract review
- Consolidated financial statements reporting; month end, quarter end & year end close; deferred revenue calculation & reconciliation
- Preparation & Calculation of Revenue Schedule, ARR & MRR Monthly Commission generation; reporting, Sales & Use Tax Returns, UK & India tax schedule preparation; India & UK Statutory financials final compilation & review; Zimbra Inc. US & State Tax Return Schedule Preparation, India & UK Legal Entity Closure;
- ESPP, FAS123R, PR schedule preparation & reconciliation, 1099 preparation
- OTC Integration, ERP System Conversion from Peachtree to Oracle 11i, Salesforce CRM to Order/Invoice Reconciliation, Corp HQ Allocation, PSI Integration, various ad hoc projects & reports preparation

Marilou Brezinka